Davidson Kempner Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Davidson Kempner Capital Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-311,623	Closed	-$16.4M	–	287
2026 Q1	$16.4M	Buy	+311,623	New	+$12.8M	0.2%	98

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Davidson Kempner Capital Management's TERN Position: Q2 2026 in Review

Davidson Kempner Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 311,623 shares — an estimated $16.4M sold.

Davidson Kempner Capital Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $16.4M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Davidson Kempner Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Davidson Kempner Capital Management sold 311,623 Terns Pharmaceuticals shares in Q2 2026, an estimated $16.4M.
Davidson Kempner Capital Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Davidson Kempner Capital Management's Terns Pharmaceuticals position peaked at $16.4M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.